IU Simon Cancer Center

Researchers

• Programs
  • Breast Cancer
  • Cancer Control
  • Experimental and Developmental Therapeutics
  • Hematopoiesis, Microenvironment and Immunology
• Member Directory
• Become a Member
  • Criteria
  • Benefits
  • Responsibilities
  • Application
• Shared Facilities
  • Angiogenesis & Endothelial Progenitor Cell
  • Biological Microscopy
  • Biostatistics & Data Management
  • Clinical Pharmacology Analytical Core
  • Chemical Genomics
  • Chemical Synthesis
  • Clinical Research Office
  • Flow Cytometry
  • In Vivo Biomedical Imaging
  • Transgenic and Knock-Out Mouse
  • Translational Genomics
  • In Vivo Therapeutics
  • Tissue Procurement and Distribution
  • Vector Production
• Funding Opportunities
  • NIH Funding
  • Bridge Funding
  • Support for Clinical Trials
  • ITRAC
  • Other Funding Opportunities
• Research Resources

You are here: Researchers > Funding Opportunities > ITRAC

ITRAC

The Indiana University Melvin and Bren Simon Cancer Center Translational Research Acceleration Collaboration (ITRAC), open to all members/affiliates of the IU Simon Cancer Center, is designed to financially assist investigators in moving their projects to external grant submission status (R21, R01, etc.). All projects/proposals must be mapped prior to proposal submission. ITRAC resources will be made available to applicants for the mapping process. If you're a member/affiliate of the IU Simon Cancer Center, please visit the ITRAC Group Site for further details including process, requirements and deadlines.

To learn more, watch Dr. Mark Kelley on "Inside Indiana Business" talk about ITRAC. Watch here.